The PAPP-A test is a diagnostic tool used to measure the levels of pregnancy-associated plasma protein A in the blood. This protein is primarily produced during early pregnancy and plays a crucial role in fetal development. By analyzing the PAPP-A levels, healthcare professionals can potentially identify any abnormalities or potential risks associated with pregnancy, allowing for timely intervention and personalized care for expectant mothers.
To continue booking, you need to select at least 1 test
* Results are available same day by 9 p.m. 99% of the time. On rare occasions, it may take up to 3 business days to receive results.
Pregnancy-associated plasma protein A (PAPP-A) is a protein that is abundantly produced during pregnancy and serves as a risk indicator for Down syndrome and other chromosomal abnormalities in prenatal screening during the first trimester. It is typically prescribed alongside the beta subunit of chorionic gonadotropin and an ultrasound examination of the portal space. This comprehensive screening is recommended for detecting fetal chromosomal abnormalities in the early stages of pregnancy (at 10-13 weeks). The most informative time to measure PAPP-A alone is between 8-9 weeks, as after 14 weeks, it loses its value as a reliable marker for chromosomal abnormalities, as even pathological pregnancies will show normal levels.
Research is conducted primarily for identifying potential chromosomal abnormalities in the fetus, assessing the risk of premature termination of pregnancy or miscarriage, and predicting the progress of pregnancy. The study is typically scheduled during the first trimester of pregnancy, preferably between the 10th and 13th week, especially when there are risk factors such as advanced maternal age, previous history of miscarriage or complications during pregnancy, genetic disorders in the family, exposure to radiation, infections or medications with teratogenic effects during early pregnancy. In males and non-pregnant females, PAPP-A protein is present in small quantities. However, in acute coronary syndrome and unstable angina, an elevation in PAPP-A levels is observed following damage to atherosclerotic plaques. It should be noted that detecting changes in biochemical markers in the mother's blood is not a definite confirmation of fetal abnormalities. It is necessary to evaluate other risk factors in combination with these markers to determine the need for more advanced diagnostic methods.
How to properly prepare for research?
On an empty stomach (8-12 hours of fasting); for children under two years of age, fasting for 2-3 hours is possible. For a day, exclude physical and emotional stress, overheating and hypothermia, sleep disturbance, air travel, instrumental research methods (ultrasound, X-ray, etc.), physiotherapy, massage, alcohol and medication (the latter - only in agreement with the doctor!). If it is not possible to exclude the medication, it is necessary to inform the laboratory when placing an order. Do not smoke one hour before blood sampling. On the day of the study, a small amount of water is allowed. Before manipulation procedures, you should take a comfortable position, relax and calm down. Important: at the gestational age indicated by the doctor. Reference limits are only for 10-13 weeks of pregnancy.
What can affect the result?
With multiple pregnancies, the content of PAPP-A in the mother's blood increases, and it is difficult to assess the likelihood of chromosomal abnormalities. If the fetus's gestational age is incorrectly determined, the
result may be erroneously raised or lowered.
A PAPP-A blood test measures pregnancy-associated plasma protein-A (PAPP-A) levels in the body. The placenta produces PAPP-A during pregnancy and is crucial in supporting fetal development. The test is important because abnormal levels of PAPP-A may indicate an increased risk of certain complications, such as chromosomal abnormalities or preterm birth. By monitoring PAPP-A levels, healthcare providers can assess the health of the pregnancy and make informed decisions regarding further testing or interventions if necessary.
In addition to measuring PAPP-A levels, the PAPP-A blood test is often used with other tests, such as ultrasound and maternal serum screening, to assess the risk of chromosomal abnormalities and other complications during pregnancy. Abnormal levels of PAPP-A in combination with abnormal levels of other proteins, such as human chorionic gonadotropin (hCG), can indicate an increased risk of chromosomal abnormalities, such as Down syndrome. Moreover, a low PAPP-A level has been associated with an increased risk of fetal growth restriction and preterm birth. By using the PAPP-A blood test as part of the first-trimester screening process, healthcare providers can identify pregnancies at a higher risk of complications and provide appropriate management and care.
There are usually no specific preparations or guidelines to follow before undergoing a PAPP A lab test. It is a simple blood draw that can be performed anytime during the day without fasting or special instructions. However, it is always advisable to consult with your healthcare provider or the laboratory conducting the test for any specific instructions they may have. They will provide you with any necessary information or precautions to ensure accurate and reliable results.
The PAPP-A blood test is typically performed between 9 and 13 weeks of pregnancy as part of the first-trimester screening process. This screening process includes an ultrasound exam, maternal serum screening, and other tests that assess the risk of chromosomal abnormalities and other complications during pregnancy. The PAPP-A blood test is an important component of this screening process because it can provide information about the risk of adverse pregnancy outcomes, such as preterm birth and fetal growth restriction. The results of the PAPP-A blood test, in combination with the results of other tests, can help healthcare providers determine whether additional testing or management is necessary. You can sign up online for testing and conveniently take our laboratory's PAPP-A blood test in Montreal.
Certain medications, supplements, and lifestyle factors can affect the results of a PAPP-A blood test. It is important to inform your healthcare provider about any medications or supplements you are taking, as they may influence PAPP-A levels. Additionally, smoking has been associated with lower PAPP-A levels, so it is crucial to disclose your smoking status to ensure an accurate interpretation of the results. Your healthcare provider will consider these factors and make appropriate adjustments when interpreting the PAPP-A blood test results, taking into account any potential impact on the accuracy of the assessment.
The time it takes to receive the results of a PAPP-A blood test may vary depending on the laboratory and the specific testing protocol. Generally, results are available within a few days to a week. You can perform the PAPP-A test in Montreal at our nearby laboratory, ensuring fast and seamless results are delivered within 24 hours. It is important to note that the test results should be interpreted in consultation with your healthcare provider, who can provide a detailed analysis and explanation based on your circumstances. They will consider various factors, such as your age, medical history, and other test results, to provide you with a comprehensive understanding of the results and any necessary follow-up actions or additional testing.
Best Prices
Our fully automated private laboratory with cutting edge technology is able to reduce costs while increasing consistency and reproducibility of results.
Faster Service
We have designed our clinics and testing processes to be efficient, reducing wait times and time for results.
More Precise Information
Our test reports provide more precise information on test results, making it easier to monitor any changes in your health over time.
Free Parking
All our clinics provide free and available parking, helping you to save even more money and time.
Customer Support
Our online booking portal and helpful testing center staff help to make diagnostic testing more convenient and compassionate.
IMPLEMENT AFFORDABLE ACTION
Companies and institutions can deploy large-scale diagnostic testing at a fraction of the cost of testing centers with Lilium’s automated laboratory testing platforms and reporting.
STAY AHEAD OF OUTBREAKS
Lilium's pioneering testing system secures workplaces and communities against expensive shutdowns by keeping businesses and organizations ahead of outbreaks.
REDUCE RISKS
Robotic analysis improves accuracy of results by drastically reducing the risk of false negatives and positives.
To make an appointment, please choose from one of our clinics below:
Monday - Saturday
7:00 - 10:00
12:00 - 15:00
We provide FREE parking at our convenient locations
Our downtown Montreal location is located on the mezzanine level of the Alexis Nihon Center with 1 hour free indoor parking. Atwater metro station has a direct inside connection to Alexis Nihon.
If you’re driving to our Laval location, we are right off Autoroute 15 and have plenty of free parking.
If you arrive by public metro, there is a walkway to our lab from Metro Montmorency (a 20 minute walk).
What our customers say about us
ASK US ANYTHING
We're here to help make sense of it all.
Or send us an e-mail